Hyaluronic Acid (Oral)
Ingested moisture molecule for skin hydration — promising but debated
Mixed evidence
✨Joint & Skin
Evidence tier
Mixed
Research weight
Citations
17 verified / 17
Classification
Joint & Skin
❝
What the evidence says. Conflicting results across studies; benefit uncertain.
What is Hyaluronic Acid (Oral)?
Hyaluronic Acid (Oral) is a joint and skin supplement used for may increase skin hydration. NutriDex grades the human evidence as Mixed. Hyaluronic acid (HA) is a glycosaminoglycan abundant in skin that binds water and supports the extracellular matrix. Several small RCTs (mostly 120 mg/day for 6–12 weeks) report improved skin moisture and reduced crow's-feet wrinkles, but they are small and largely funded by HA manufacturers. The bioavailability of oral HA is debated — ingested HA is broken down by gut bacteria, so any benefit likely comes from fragment signaling or microbiota effects rather than intact HA reaching the skin. Reflecting this uncertainty, an independent 2025 meta-analysis found no significant benefit of oral HA for skin photoaging. Oral HA also has preliminary, weak evidence for mild knee osteoarthritis.
Purported Benefits
✓May increase skin hydration
✓Possible reduction in wrinkle depth
✓May improve elasticity
✓Reduced subjective dryness
Evidence by outcome
The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.
| Outcome | Evidence | Effect | Studies |
|---|---|---|---|
| Increased skin hydrationSeveral manufacturer-linked RCTs and a 2025 meta-analysis show benefit, but an independent meta-analysis found none. | Mixed | ↑ benefit · small | 6 |
| Reduced wrinkle depthPooled analysis shows reduced depth but wrinkle volume non-significant; industry-funded trials. | Mixed | ↔ mixed · small | 4 |
| Improved skin elasticityMeta-analysis significant for elasticity but firmness not; mostly small sponsored RCTs. | Mixed | ↑ benefit · small | 3 |
| Skin photoaging (overall)Independent 2025 meta-analysis found no significant benefit for photoaging. | Mixed | — no effect · negligible | 1 |
| Reduced knee osteoarthritis painA systematic review and small RCTs favor benefit, but one combination-product RCT was null. | Preliminary | ↑ benefit · small | 3 |
Dosing & Compounds
Typical Dose
120–240 mg/day (most trials used 120 mg/day for 6–12 weeks).
Active Compounds
Safety & Cautions
Generally well tolerated in short trials (≤12 weeks) with no serious adverse events; long-term data are lacking and reassurance comes from small industry-sponsored studies. No clinical evidence links oral HA to cancer, but those with active malignancy or who are pregnant/breastfeeding should consult a clinician given the absence of data. Educational only — always check with your doctor or pharmacist before combining Hyaluronic Acid (Oral) with any medicine.
Key Studies ★ 17 studies
Meta-analysis
Yang 2025 (Meta-analysis)
✓ Full text
Pooled HA data (2 studies, n=100) showed no significant difference vs placebo for skin photoaging (SMD 1.88, p=0.21).
Systematic review
Mazzucco 2024 (Systematic review)
✓ PubMed
Systematic review of 11 trials (597 patients, mostly randomized placebo-controlled) found 9/11 reported improvement in osteoarthritis/low back pain measures (VAS pain, WOMAC, Lequesne) with oral HA (30-300 mg/day); adverse effects rare and mild.
meta-analysis
Amin 2025 (Meta-analysis)
✓ PubMed
Meta-analysis pooling 7 randomized controlled trials of oral hyaluronic acid found statistically significant improvements in skin hydration and elasticity and a significant reduction in wrinkle depth versus placebo, though firmness, wrinkle volume, and transepidermal water loss did not reach significance.
RCT
Dolečková 2025 (RCT)
✓ PubMed
Randomized double-blind placebo-controlled trial in 150 healthy adults; 120 mg/day oral sodium hyaluronate for 12 weeks significantly improved skin hydration and elasticity and reduced TEWL, sebum, and periorbital wrinkle depth vs placebo (60 mg/day showed more modest effects).
RCT
Gao 2023 (RCT)
✓ PubMed
Double-blind RCT in 129 women; oral HA at 100 or 200 mg/day for 12 weeks significantly improved skin hydration (weeks 2-8) and skin tone (weeks 4-8) and increased epidermal thickness at 12 weeks vs placebo.
RCT
Sugiyama 2023 (RCT)
✓ Full text
Randomized double-blind placebo-controlled trial in 31 adults with knee discomfort; 111 mg/day oral sodium hyaluronate for 12 weeks significantly lowered VAS scores for knee pain/stiffness/discomfort vs placebo at 6 and 12 weeks, with no adverse effects.
rct
Puch 2025 (RCT)
✓ PubMed
Randomized double-blind placebo-controlled trial in 50 completing adults; 60 mg/day of an oral hyaluronic acid matrix (Dermial) for 12 weeks significantly increased skin brightness and stratum corneum hydration and reduced roughness, scaliness, and erythema versus placebo, with no serious adverse events.
RCT
Michelotti 2025
✓ Full text
In a 12-week double-blind RCT of 150 healthy adults, oral sodium hyaluronate increased cheek skin hydration by +9.1% (60 mg/day) and +11.5% (120 mg/day) vs placebo (p<0.05), with reduced transepidermal water loss and periorbital wrinkles at 120 mg/day.
RCT
Skin Res Technol 2023
✓ Full text
In a 12-week double-blind RCT of 129 women (young and elderly), oral 300 kDa hyaluronic acid at 100 and 200 mg/day significantly improved skin hydration from 2-8 weeks in both age groups and increased epidermal thickness at 12 weeks (p<0.05).
RCT
Hill et al. 2023 (Nutrients RCT)
✓ PubMed
12-week multicenter RCT (n=100) of a krill oil/astaxanthin/low-MW oral HA complex in mild knee/hip OA: significantly greater reduction in VAS joint pain (20.8 vs 10.6 mm) and improvement in total WOMAC (-13.0 vs -5.5) and function vs placebo, with fewer adverse events; HA was a combination-product component.
RCT
Hsu/Oe et al. 2021 (Nutrients RCT)
✓ PubMed
12-week double-blind, placebo-controlled trial in 40 adults (35-64 y): oral HA 120 mg/day significantly improved wrinkle assessment, stratum corneum water content, transepidermal water loss, and skin elasticity vs placebo, with significant percentage-change benefits in wrinkles, hydration, and elasticity from 8 weeks onward.
RCT
Cicero et al. 2020 (Diseases RCT)
✓ PubMed
Double-blind, randomized, placebo-controlled trial in 60 symptomatic knee OA patients: oral full-spectrum sodium hyaluronate significantly reduced VAS pain and WOMAC pain scores at 60 days vs placebo and significantly cut weekly NSAID/analgesic use.
RCT
Wang et al. 2021 (Medicine RCT, null)
✓ PubMed
8-week double-blind, placebo-controlled trial (n=80) of a liquid low-MW HA + glucosamine + chondroitin supplement in moderate knee OA pain found NO significant improvement over placebo in KOOS, WOMAC, SF-36, or sleep quality, though SF-36 trends were numerically higher; tempers efficacy claims for combination oral HA.
RCT
Oe 2017 (RCT)
✓ PubMed
Double-blind RCT in 60 adults with crow's feet; 120 mg/day HA for 12 weeks improved wrinkle area and volume vs placebo. (Manufacturer-employed authors.)
RCT
Kim 2019 (RCT)
✓ PubMed
Prospective randomized controlled trial in 54 dry eye disease patients; adding oral hyaluronic acid to topical HA significantly improved OSDI symptom scores (61.8 to 42.3 at 3 months), tear break-up time, and corneal fluorescein staining versus topical HA alone.
RCT
Kawada 2014 (RCT)
✓ Full text
Double-blind placebo-controlled trial; 120 mg/day ingested hyaluronan for 6 weeks significantly increased skin moisture in adults with dry skin.
RCT
Palmieri 2013 (RCT)
✓ PubMed
Randomized double-blind placebo-controlled crossover trial in 20 PPI-refractory non-erosive GERD patients; an oral bioadhesive hyaluronic acid plus chondroitin sulfate formulation (four daily doses, 14 days) significantly reduced overall symptom intensity, heartburn, and acid regurgitation, with symptom resolution in 50% vs 10% on placebo.